참가신청

HOME  >  교육 및 행사  >  참가신청
교육명 Get ready for Phar-East 2019 분류 기타
신청일정 2019.03.04~2019.03.15 행사일정 2019.03.19~2019.03.20
장소 World Resort Convention Center, Singapore 시간

상세안내

Save 50% when you buy in groups of 3 or more
Get ready for Phar East 2019!
Record pharma & biotech attendance!
Get facetime with leading pharma & biotech experts!
Meet your 140+ 2019 speakers
  • Jun Feng, Market Access Associate Director - Oncology, JAPAC, AbbVie, Singapore 
  • Du Xin, Global Head of Regulatory Affairs, Adlai Nortye Biopharma, USA
  • Ian Huen, CEO, Aptorum Group, Hong Kong, China
  • Carl Firth, CEO, ASLAN Pharma, Singapore
  • Harish Dave, Chief Medical Officer, AUM Biosciences, Singapore
  • Vishal Doshi, CEO, AUM Biosciences, Singapore
  • Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo, India
  • Vivian Bian, COO, BeiGene, China
  • Amit Kumar, Co-Founder & CEO, Biopsin, Singapore
  • Dwo Yuan Sia, Chief Technology Officer, BravoVax, China
  • Meng Chi Chen, Director, Business Development, BRIM Biotechnology, Taiwan
  • Anthony Desir, Director, Cancelex, Hong Kong
  • Nir Arbel, Cofounder & CEO, Carmentix, Singapore
  • Alexandre Civiere, Project Manager, Cell Prothera, Singapore
  • Charles Stacey, CEO, Cerecin, Singapore
  • Judy Walker, Chief Medical Officer, Cerecin, Singapore
  • Wei Jiang Goh, Co-Founder & CEO, Craft Health, Singapore
  • Frank Jiang, CEO, CStone, China
  • Stefan Glück, Vice President, Global Medical Affairs, Celgene, USA
  • David Benshoof Klein, CEO and Founder, Click Therapeutics, USA
  • Ed Rosen, Leader, Glendevon Life Sciences LLC, Executive in Residence, Columbia Technology Ventures, USA
  • Ignacio Asial, Founder & CEO, DOTBIO, Singapore 
  • Pratapa S, Former Senior Director, Dr Reddy’s Laboratories, India
  • Pei Yin Tan, Director, Asia Clinical Operations, Medicine Development Center, Eisai Clinical Research, Singapore
  • Jeonghoon Han, Vice President Chief Development Officer and Chief Financial Officer, Eutilex, South Korea
  • Marcel van Duin, Vice President, Therapeutic Area Head Reproductive Health & Endocrinology Research, Ferring Pharmaceuticals, Netherlands
  • Carrie Hillyard, Chairman, Fitgenes, Australia
  • Crystal Sun, Assistant CEO & Director, Regulatory & Government Affairs, Fosun Kite Biotechnology, China
  • Sam Shen, QA Director, Fosun Kite Biotechnology Co.,Ltd., China
  • TS Balganesh, President, Ganga Gen, India
  • Qin Gang, President, GeneQuantum Healthcare (Suzhou), China
  • Hoon Seong, Deputy Manager, Genome & Company, South Korea
  • Mahboob Rahman, Executive VP & Head, Clinical Sciences, Glenmark Pharmaceuticals, Singapore 
  • Maggie Lim, Director, Clinical Quality Assurance, Pharma R&D, APAC, Global Quality Assurance, R&D Chief Regulatory Office, GSK, Singapore
  • Maijing Liao, Senior Vice President, Head of Business Development and Portfolio Management, Harbour BioMed, China
  • Mario Bertazzoli, Director, Group Head of Drug Safety, Helsinn Healthcare, Switzerland
  • Jeffrey Dao, Operating Officer & Business Development Officer, HighTide Therapeutics, USA
  • Yau Teng Yan, Chief Medical Officer, Holmusk, Singapore
  • Piers Ingram, CEO, Hummingbird Biosciences, Singapore
  • Sabrina Ng, Chief Financial Officer, Hummingbird Biosciences, Singapore
  • Maria Chen, Director, Business Development, Immunwork, Taiwan
  • Wenzhi Tian, MD, Chairman, CEO, ImmuneOnco Biopharma, China
  • Nick Ede, Chief Technology Officer, Imugene, Australia
  • George Kopsidas, Executive Director and Chief Scientific Officer, Imunexus, Australia
  • Anil Pareek, President, Medical Affairs and Clinical Research, IPCA, India
  • Nathan Kothadaraman, Director, Market Access and Government Affairs, Janssen, Malaysia
  • James Garner, CEO, Kazia Therapeutics, Australia
  • Chongdeok Park, Chief Development Officer, Kolon Pharmaceuticals, South Korea
  • Dean Ho, Co – Founder, KYAN Therapeutics, Singapore
  • Kamal Amin, Senior Clinical Supply Manager, Fujifilm Kyowa Kirin Biologics, UK
  • Andreas Koester, Vice President, Clinical Trial Innovation & External Alliances, Janssen, J&J, USA
  • Vicky Han, Senior Director, Regulatory Policy Group Lead, Janssen, J&J, Singapore
  • Victor Li, CEO, LionTCR, Singapore
  • Antonio Bertoletti, Co-Founder, LionTCR, Singapore
  • Ken Taylor, CEO, Living Cells Technologies, New Zealand
  • Stephanie Liu, Medical, Regulatory & Clinical Quality Assurance (MRC QA) Lead, Lundbeck, Singapore
  • Gopal Rao, Global Business Development and Services Outsourcing, Lupin, India
  • Antonio Lee, Global Head of Business Development, MEDIPOST, CEO & Managing Director, MEDIPOST AMERICA, South Korea
  • Bechara Saab, CEO, Mobio Interactive, China
  • Jason Widjaja, Associate Director, Global Data Science (AI & Data Products), MSD, Singapore
  • Dong-Hun Woo, Chief Operating & Technology Officer, Nexel, South Korea
  • Kum Cheun (KC) Wong, Head of Asia Pacific, Regulatory and Development Policy, Novartis, Singapore
  • Ogan Gurel, Founder & CEO, NovumWaves, South Korea
  • Shwen Gwee, General Manager, Digital Accelerator (Global Drug Development), Novartis, USA
  • Xichen Lin, Research Director, Search & Evaluation, Novo Nordisk, China
  • Jason Orbaugh, Director of Business Development, Path Therapeutics Inc, Canada
  • Anand Gautam, Head of External Science & Innovation, Pfizer, Australia
  • Toru Seo, APAC Head, S&E, Worldwide Business Development, Chief Business Office, Pfizer, Japan
  • Handsome Ji, APAC publishing lead, Pfizer, China
  • Enver Erkan, Country Manager, Pfizer, Singapore
  • Yuliana Indriati, President Director, PT Kalbe Genexine, Indonesia
  • Mario Gattino, CEO, Respiri, Australia
  • Finny Liu, PDR APAC Regulatory Policy Lead, Roche, Singapore
  • Hyejin Shin, Director, Group Leader, Clinical QA, Samsung Bioepis, South Korea
  • Shailendra Bajpai, Global Head of Disease Management, Sanofi, Singapore
  • Yong Ho Oh, Regional Clinical Project Manager, ISS Project Manager, Sanofi, Singapore
  • Evelyn Pang, Head of Operations, Sanofi Pasteur, Singapore
  • Byung-Geon (BG) Rhee, CEO, SCM Lifesciences, Chairman, Council for Advanced Regenerative Medicine, Former President, Green Cross Corporation, South Korea
  • Gloria Wang, Chief Medical Officer, Shanghai Sinobioway Sunterra Biotech, China
  • Liping Liu, Founder, CEO& CSO, ShenZhen HighTide Biopharmaceuticals, China
  • John Patava, Global Head of Scientific Affairs, Sirtex Medical, Australia
  • Raphael Aswin, Vice President R&D and Regulatory, SOHO Global Health, Indonesia
  • Jeong Beom Kim, CEO, SuPine Therapeutics Co. Ltd, South Korea
  • Philippe Pinton, Regional Head, Specialty Therapy, Takeda, Japan
  • Susanne Weissbacker, Global Head of Access to Medicines, Takeda, Singapore
  • Aung Myo, Vice President, Clinical Development, Tessa Therapeutics, Singapore
  • Josemund Menezes, Director, Medical Affairs & Clinical Development, Tessa Therapeutics, Singapore
  • Alexander Kort, SVP Corporate Development, Themis Bioscience, Austria
  • Seok Joong Kim, Board Member, Director and Head of Business Development, Toolgen, South Korea
  • William Jia, CSO, Virogen Biotech, China
  • Younggyu Cho, Chief Technology Officer, Y-Biologics, South Korea
  • Jang Woo Shin, Senior Principal Scientist, R&D Strategy & Planning Team, Yuhan R&D Institute, South Korea
  • Robert Yu, Senior Vice President, Operations, Yuyu Pharma, South Korea
  • Billy Cho, CFO, Zai laboratories, China
  • Abraham Cinta, CEO, ARC Capital, Singapore 
  • Gavin Teo, General Partner, B Capital, USA
  • Sean Cao, Managing Director, C-Bridge Capital Partners LLC, USA
  • Haolin Sung, Director, Direct Investment Department, Diamond BioFund, Taiwan
  • Sinclair Dunlop, Managing Director, Epidarex Capital, UK
  • Xiangqian (XQ) Lin, Managing Partner, Esco Ventures, Singapore
  • Ashish Patel, Head of Research, Investment Manager, Mercia Technologies PLC, UK
  • Jeffry Wu, Managing Director, Milestone Capital, China
  • Hironoshin Nomura, Senior Analyst, Mizuho Securities, Japan
  • Alfred Scheidegger, Partner& Founder, Nextech Invest, Switzerland
  • Marietta Wu, Managing Partner, Quan Capital, China
  • Joseph Mocanu, Managing Director, Verge Capital Management, Singapore
  • Donald Xu, Managing Director, Lynx Financial, China
  • Atsushi Usami, Partner, University of Tokyo Edge Capital (U-TEC), Japan 
  • Sir David Lane, Chief Scientist, A*STAR, Singapore 
  • Mrunalini Jagtap, Data Management Lead, Singapore Institute for Clinical Sciences (SICS), A*STAR, Singapore
  • Nathanael Faibis, CEO, Alodokter, Indonesia 
  • Nitin Jain , VP Asia Pacific, Ancillare, Singapore 
  • Raghu Bathina, CEO, Celes Care, Founder, Future World Studios, India
  • Lynne Baxter, Team Leader Clinical Study Research, Danone Nutriticia Research, Singapore
  • Fiona Wong, Team Leader Clinical Studies ASPAC, Danone Nutriticia Research, Singapore
  • Salah Uddin, Assistant Director, Directorate General of Drug Administration, Bangladesh
  • Reenita Das, Partner, Frost & Sullivan, USA
  • Mohd Fazli Shuib, Head, Pharmacy Services, FV Hospital, Vietnam
  • Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute, South Korea 
  • Andrew Gebbie, Principal Solution Consultant, Medidata Solutions, United Kingdom
  • Aparajeeta Priyadarasini, Solution Consultant, Medidata Solutions, India
  • Edwin Ng, Vice President, Field Operations, APeJ, Medidata Solutions, Singapore
  • Ross Rothmeier, Vice President Tech Solutions, Medidata Solutions, USA
  • Keita Maeda, Deputy Director of Bio-Industry Division, Ministry of Economy, Trade and Industry (METI), Japan
  • Phusit Prakongsai, Acting Senior Advisor, Health Promotion, Office of Permanent Secretary, Ministry of Public Health, Thailand
  • Nadia Suttikulpanich, Head of Fuchsia Innovation Center, Muang Thai Life Assurance, Thailand 
  • Sophie Tsou, Associate Investigator, Division of Biostatistic and Bioinformatics, Institute of Population Health Sciences, National Health Research Institute, Taiwan
  • Matt Cooper, Business Development and Marketing Director, NIHR Clinical Research Network, UK
  • Mayank Gurnani, Associate Professor, Industry Liaison Office, National University of Singapore, Singapore
  • Teck Jack Tan, Chairman & Medical Director, Northeast Medical Group, Singapore
  • Henry Ines, CEO, Project Shivom, USA
  • JingPing Yeo, Director, Research Integrity, Compliance, Ethics, Singapore Health Services, Singapore
  • Tong Hsien-Hui, Head, Venture Investing, SGInnovate, Singapore
  • Poh Loong Soong, Founder & CEO, Ternion Biosciences, Singapore
  • I-Ning Tang, Team Leader, Center of Consultation, Taiwan Center for Drug Evaluation, Taiwan
  • Donna Collett, Managing Partner, Valeur Consulting, Australia
  • Chervee Ho, Director of Key Account Management Asia Pacific, Vetter Pharma International, Singapore
  • Edmund Lim, Co-Founder and President, WeCareJourney, Malaysia
Meet exciting biotechs ready to take it to the next level in our Biotech Inve$t track
Enhance your experience with our exciting pre-event workshops
Meet 50+ solution partners
What are you waiting for? Join us!